Skip to content
BioFutureRx
HomeBiologicsPeptidesPartner With UsAboutContactContact BioFutureRx

Biopharmaceutical Company · Biologics & Peptides

Advancing Biologic Medicines for a Healthier Future

BioFutureRx is focused on biologic medicines — biosimilars, first-in-class antibodies, diagnostics, and delivery platforms — and develops its own peptide therapeutics in-house, led by its lead asset, BFRx3711, a novel long-acting GLP-1.

Explore Our Biologics FocusPartner With Us

A Biopharmaceutical Company

Biologic medicines, advanced from discovery to market

BioFutureRx is a biopharmaceutical company focused on biologic medicines — spanning biosimilars, first-in-class antibodies, diagnostics, and delivery platforms — and it engineers its own peptide therapeutics in-house, led by its lead asset, BFRx3711.

Why BioFutureRx

Our focus across biologics and peptides

A Focus on Biologics

Biosimilars, first-in-class and novel antibodies, diagnostics, and delivery platforms — the areas of biologic medicine where we concentrate our work.

First-in-Class Ambition

An interest in novel-target antibody discovery and engineering across oncology, immunology, and other areas of unmet medical need.

Our Own Peptide Program

BFRx3711, a proprietary in-house GLP-1 analog engineered for potential once-monthly dosing — the company's lead asset.

Biologics

Our focus in biologic medicine

The areas we concentrate on — biosimilars, novel and first-in-class antibodies, companion diagnostics, and drug-delivery platforms.

Learn more

Peptides

Inside our peptide program

BFRx3711, our proprietary long-acting GLP-1 analog engineered in-house for potential once-monthly dosing in obesity and type 2 diabetes.

Learn more

Partner with us to advance biologic medicines.

Contact BioFutureRx

Our Network

Part of a connected group.

BioFutureRx works alongside sister companies across pharmaceutical licensing, capital, and marketplace — explore the wider network.